在印度,对试验药物的试验后获取:解决监管框架中的挑战
Nidhi Mehrotra1, Padmavati Manchikanti1
1Rajiv Gandhi School of Intellectual Property Law, Indian Institute of Technology Kharagpur, Kharagpur, India.
Medical law review
|August 24, 2023
概括
印度 印度 印度
科学领域:
- 制药法律和法规 制药法律和法规
- 临床试验伦理学研究
- 药物发展政策 药物发展政策
背景情况:
- 印度2019年新药和临床试验规则 (2019年规则) 规定了试验后访问 (PTA).
- 现有法规显示了2019年规则和ICMR指南2017年之间的不一致性.
- 这些差距对试验参与者造成伤害,特别是那些获得医疗保健有限的人.
研究的目的:
- 分析印度目前的审判后访问监管框架中的挑战.
- 提出改善PTA条款和解决监管差距的战略.
- 将印度定位为为临床试验东道国建立全面的PTA指南的领导者.
主要方法:
- 分析新药和临床试验规则,2019年和ICMR指南2017年.
- 识别PTA中的不一致性和解释挑战.
- 制定拟议的战略,以提高监管清晰度和参与者访问.
主要成果:
- 印度目前的PTA法规不一致,对参与者构成风险.
- 缺乏关于"富有同情心的使用"或"扩大访问"的明确规定.
- 拟议的战略旨在为利益相关者创造"双赢"并改善参与者福利.
结论:
- 印度需要完善其对新药试验后获取新药的监管框架.
- 制定明确的PTA条款可以加强参与者的保护,并促进对临床试验的信任.
- 印度有可能在全球范围内引领建立审判后访问的最佳实践.
相关概念视频
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Drug Control Governance: Regulatory Bodies and Their Impact
184
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
184
Pharmacovigilance
889
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
889
Clinical Trials
6.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.8K
Preclinical Development: Overview
4.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K


